261 filings
8-K
AMAG
Amag Pharmaceuticals, Inc.
17 Nov 20
Entry into a Material Definitive Agreement
12:00am
8-K
AMAG
Amag Pharmaceuticals, Inc.
17 Nov 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
AMAG
Amag Pharmaceuticals, Inc.
5 Oct 20
Regulation FD Disclosure
9:56pm
8-K
AMAG
Amag Pharmaceuticals, Inc.
1 Oct 20
Entry into a Material Definitive Agreement
4:57pm
8-K
AMAG
Amag Pharmaceuticals, Inc.
17 Aug 20
Other Events
4:41pm
8-K
m7gcu2
6 Aug 20
Amag Pharmaceuticals Announces Second Quarter 2020 Financial Results
7:06am
8-K
j9gxedh4m4nu34m1
27 Jul 20
Amag Pharmaceuticals Completes Divestment of Women’s Health Assets
7:38am
8-K
w1ok6 u2g91s
23 Jul 20
Amag Pharmaceuticals and Norgine B.V. Enter into Exclusive Licensing Agreement to Commercialize Ciraparantag In Europe, Australia and New Zealand
9:24am
8-K
7yz2vq4 172ng
11 Jun 20
Amag Pharmaceuticals Announces Leadership Changes
7:13am
8-K
o4egz9
4 Jun 20
Submission of Matters to a Vote of Security Holders
4:41pm
8-K
vab6dix6e7vlgcbose
21 May 20
Amag Pharmaceuticals Completes Sale of Its Rights to Intrarosa® to Millicent Pharma for Up to $125 Million
9:34pm
8-K
nflr7lubh hd
11 May 20
Amag Pharmaceuticals Announces First Quarter 2020 Financial Results
7:18am
8-K
v08l5pqpxvb6kfm2288s
28 Apr 20
AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer
7:34am
8-K
xzfgxtyh qaiyn
16 Apr 20
Amag Pharmaceuticals Provides COVID-19 Company Update
7:45am
8-K
r7f3br7a
4 Mar 20
Amag Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
7:07am
8-K
24rfh8at2ssznd dz1t
9 Jan 20
AMAG Pharmaceuticals Announces Leadership Transition, Results of Strategic Review
7:15am
8-K
j9xh2 r4rsdgw254t2y
3 Dec 19
Departure of Directors or Certain Officers
4:13pm
8-K
3g5s7ua69hx5d dj6lls
1 Nov 19
Amag Pharmaceuticals Announces Third Quarter 2019 Financial Results
7:03am
8-K
p876xr3u d06
30 Oct 19
Amag Reports on Fda Advisory Committee Meeting for Company to Comment During Third Quarter Financial Results Conference Call on
7:46am
8-K
wy4x crj66138qxs5pq6
8 Oct 19
AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP
10:20am